Following implantation of D5-HER2 cells in hmHER2Tg mice, the mice were randomly assigned to 2 large cohorts, one receiving 2.4G2 antibody starting on day 0 (the day of tumor cell implantation) and the other not receiving 2.4G2 antibody. Here, ERBB2 is linked to neoplasm.